r-tPA

DRUG3 trials

Sponsors

Thrombolex, Inc.

Conditions

Pulmonary Embolism

Phase 1

First - In - Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism

CompletedNCT03927508

Thrombolex, Inc.Pulmonary Embolism

Start: 2019-03-14End: 2020-01-23Updated: 2023-03-30

Phase 3

tPA by Endovascular Administration for the Treatment of Submassive PE Using CDT for the Reduction of Thrombus Burden

CompletedNCT04248868

Thrombolex, Inc.Pulmonary Embolism

Start: 2020-06-23End: 2022-06-23Updated: 2023-04-20

Unknown Phase

The RAPID - PE Study: RESCUE Advanced Protocol for the Treatment of Pulmonary Embolism

RecruitingNCT06433011

Thrombolex, Inc.Pulmonary Embolism

Start: 2024-10-17End: 2028-04-25Target: 500Updated: 2026-07-14

Related Papers

Pharmacomechanical Catheter-Directed Thrombolysis With the Bashir Endovascular Catheter for Acute Pulmonary Embolism: The RESCUE Study.

2022-09-1747 citations

First-in-Human Study to Assess the Safety and Feasibility of the Bashir Endovascular Catheter for the Treatment of Acute Intermediate-Risk Pulmonary Embolism

Circulation Cardiovascular Interventions2020-12-2423 citations